Prostate cancer Board decisions

The Board has granted reopening of the claims for service connection for heart disease, diabetes mellitus, prostate cancer, anemia, and sleep apnea. However, the criteria for these conditions are not met as they are not related to service.

The Veteran's prostate cancer and its residuals, including urinary incontinence and erectile dysfunction, are rated at 100% from February 22, 2011, through August 22, 2011.,Beginning August 23, 2011, the Veteran is granted a 20% rating for his service-connected erectile dysfunction.

The Veteran's other specified anxiety disorder is currently rated at 30 percent, which is the maximum rating available under the General Rating Formula for Mental Disorders.,The Veteran's hypertension has been rated as 10 percent disabling since July 27, 2020.

The reduction from a 100% rating to a 30% rating for prostate cancer residuals is granted, but the Veteran's claim for an increased rating remains pending.

The Board has remanded the Veteran's claim for a new VA examination to determine the current severity of his service-connected prostate cancer, status post prostatectomy. The Veteran was given multiple opportunities for an examination but did not attend.

The Board has decided to remand the claims for service connection for heart disability, prostate cancer, and Dupuytren's disease due to a need to determine if the Veteran was exposed to Agent Orange while serving on the U.S.S. Constellation.

The Veteran's service connection claims for prostate cancer and a chronic lumbar spine disability have been granted. The claim for right ear hearing loss is remanded, as well as the initial compensable rating claim for left ear hearing loss.

The Board has remanded the case due to inadequate medical opinion regarding the relationship between the Veteran's prostate cancer and his exposure to contaminated water at Camp Lejeune. The appellant seeks service connection for the cause of her husband's death, which is related to prostate cancer.

The Board denied service connection for prostate cancer and bladder cancer, finding that the evidence did not support a link between these conditions and active service, including exposure to ionizing radiation.

The Board has remanded the cases due to insufficient verification of the Veteran's exposure to herbicide agents during service, specifically near the DMZ in Korea. The cases will be re-adjudicated after further investigation.

The Veteran's service-connected prostate cancer residuals and erectile dysfunction rendered him unable to secure and follow a substantially gainful occupation consistent with his education and work history prior to August 28, 2020. As such, the Board granted a TDIU for this period.

The Board denied service connection for prostate cancer, glaucoma, and sleep apnea. The Veteran's claims were not supported by evidence showing a direct relationship to his military service or any recognized exposure to herbicides.

The Board has dismissed the appeal for an increased rating for prostate cancer residuals. The appeals for service connection and higher ratings for skin disease, heart disease, lung disease, GERD, PTSD, and erectile dysfunction are remanded.

The Veteran's service connection claims for prostate cancer, diabetes, and hypertension have been granted. However, the claim for hypertension remains pending as it has been remanded.

The Board has remanded the Veteran's claims of service connection for chronic prostate problems and erectile dysfunction due to lack of a VA examination, outstanding private treatment records, and potential 38 U.S.C. § 1151 claim.

The Veteran's claim for a rating in excess of 10 percent for eczema of the bilateral lower extremities was denied, and his claim for TDIU prior to May 21, 2019, was also denied.

The Board has remanded the case due to insufficient evidence regarding whether the Veteran's death was caused by his service-connected tuberculosis or if it contributed significantly to his death.

The Board has remanded the case due to inadequate medical opinions regarding direct service connection for prostate cancer, and a new opinion is needed.

The Board denied service connection for prostate cancer and granted service connection for kidney cancer with an effective date of March 14, 2017. The Veteran also requested an earlier effective date for the grant of service connection for kidney cancer based on direct service connection, but this was not granted as it would be precluded by the liberalizing regulations.

The Veteran's prostate cancer and lymphoma are remanded for further examination to determine their etiology, including exposure to Agent Orange from treating servicemembers returning from Vietnam.